Cost effectiveness of continued-warfarin versus heparin-bridging therapy during pacemaker and defibrillator surgery

J Am Coll Cardiol. 2015 Mar 10;65(9):957-9. doi: 10.1016/j.jacc.2014.11.060.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / administration & dosage*
  • Anticoagulants / economics
  • Canada
  • Cost-Benefit Analysis
  • Defibrillators, Implantable*
  • Hematoma / etiology
  • Heparin / administration & dosage*
  • Heparin / economics
  • Humans
  • Length of Stay / economics
  • Pacemaker, Artificial*
  • Perioperative Period
  • Randomized Controlled Trials as Topic
  • Thromboembolism / prevention & control*
  • Warfarin / administration & dosage*
  • Warfarin / economics

Substances

  • Anticoagulants
  • Warfarin
  • Heparin